Loulis Mills S.A. (KYLO)
Athens Exchange · Greece · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 3.280 |
|---|---|
| 52-week range | 3.110 – 4.100 |
| Return, 1 month / 3 months | −6.0% / −9.6% |
| Return, 1 year / 3 years | −6.3% / +27.5% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 21.6% |
| Worst drawdown (1 year) | -22.3% |
| Average daily value traded | 0.01M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Loulis Mills is a Greek flour milling company that turns wheat and other grains into flour and cereal-based ingredients. It supplies bakeries, food manufacturers and other industrial customers with flours and related products used in bread, baked goods and prepared foods. The company is based in Greece, where its milling operations and main markets are concentrated, and it serves customers in the domestic food industry as well as export markets.
On this site Loulis Mills S.A. appears as a stock on the Athens Exchange (Greece), code KYLO, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Loulis Mills S.A. (KYLO) trades on the Athens Exchange in Greece. It last closed at EUR 3.280 on 22 October 2026.
Its price-based Market X-Ray is 41 out of 100 (a weak price profile), ranking 93 of 143 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 6.3% and over the last three months it fell 9.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Athens Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 31 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.0% | ||
| From 52-week high | -18.6% | ||
| Momentum | 25 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -9.6% | ||
| 6-month return | -17.8% | ||
| 12-month return, skipping the last month | -0.3% | ||
| Stability (higher is calmer) | 72 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.3% | ||
| Liquidity | 34 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.9% |
|---|---|
| 1 month | −6.0% |
| 3 months | −9.6% |
| 6 months | −17.8% |
| 1 year | −6.3% |
| 3 years | +27.5% |
| 5 years | +44.9% |
Signals
| 50-day / 200-day average | 3.467 / 3.684 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.098 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Jun 2023 | EUR 0.1200 |
| 27 Jun 2022 | EUR 0.0600 |
| 3 Jun 2021 | EUR 0.0600 |
| 12 Jun 2020 | EUR 0.0700 |
| 2 Aug 2019 | EUR 0.0600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Athens Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.